PROTARA THERAPEUTICS, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 3rd, 2023 • Protara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 3rd, 2023 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Protara Therapeutics, Inc. (the “Company”), and Patrick Fabbio (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”) as of June 1, 2023.
PROTARA THERAPEUTICS, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 8th, 2023 • Protara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 8th, 2023 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Protara Therapeutics, Inc. (the “Company”), and Patrick Fabbio (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”) as of January 5, 2023, and shall become effective on Executive’s commencement of employment with the Company (the “Effective Date”), which is expected to be January 30, 2023.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 5th, 2022 • Protara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 5th, 2022 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Protara Therapeutics, Inc. (the “Company”), and Jathin Bandari(“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), effective as of January 10, 2022 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 6th, 2021 • Protara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Protara Therapeutics, Inc. (the “Company”), and Martin Sebastian Olivo, M.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), effective as of April 19, 2021 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 20th, 2020 • ArTara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 20th, 2020 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between ArTara Therapeutics, Inc. (the “Company”), and Julio Casoy, MD (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), effective as of February 13, 2020 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 20th, 2020 • ArTara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 20th, 2020 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between ArTara Therapeutics, Inc. (the “Company”), and Blaine Davis (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”) as of January 31, 2020, and shall become effective on Executive’s commencement of employment with the Company (the “Effective Date”), which is expected to be February 13, 2020.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 10th, 2020 • ArTara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 10th, 2020 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between ArTara Therapeutics, Inc. (the “Company”), and Jesse Shefferman (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 10th, 2020 • ArTara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 10th, 2020 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between ArTara Therapeutics, Inc. (the “Company”), and Jacqueline Zummo, PhD, MPH, MBA (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).